Research Analysts Issue Forecasts for Humana Inc.’s FY2018 Earnings (NYSE:HUM)
Humana Inc. (NYSE:HUM) – Equities researchers at Leerink Swann dropped their FY2018 EPS estimates for shares of Humana in a note issued to investors on Thursday. Leerink Swann analyst A. Gupte now expects that the insurance provider will post earnings per share of $12.40 for the year, down from their prior forecast of $12.43. Leerink Swann currently has a “Outperform” rating and a $265.00 target price on the stock.
Several other equities analysts have also commented on HUM. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $237.00 price objective for the company in a research report on Tuesday, April 18th. Jefferies Group LLC lowered shares of Humana from a “buy” rating to a “hold” rating and decreased their price objective for the company from $237.00 to $221.00 in a research report on Friday, April 21st. Cowen and Company reaffirmed an “outperform” rating and issued a $230.00 price objective on shares of Humana in a research report on Tuesday, April 25th. Evercore ISI reaffirmed an “outperform” rating and issued a $240.00 price objective on shares of Humana in a research report on Tuesday, April 25th. Finally, Cantor Fitzgerald increased their price objective on shares of Humana from $190.00 to $200.00 and gave the company a “neutral” rating in a research report on Wednesday, April 26th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $241.65.
TRADEMARK VIOLATION NOTICE: “Research Analysts Issue Forecasts for Humana Inc.’s FY2018 Earnings (NYSE:HUM)” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.dailypolitical.com/2017/08/05/research-analysts-issue-forecasts-for-humana-inc-s-fy2018-earnings-nysehum.html.
Shares of Humana (NYSE HUM) traded down 1.17% during mid-day trading on Friday, hitting $245.93. 1,557,990 shares of the stock were exchanged. The firm has a market cap of $35.54 billion, a price-to-earnings ratio of 20.23 and a beta of 0.91. Humana has a 52-week low of $163.50 and a 52-week high of $251.79. The stock has a 50-day moving average price of $236.19 and a 200 day moving average price of $220.68.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The firm had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same period in the previous year, the business posted $2.30 earnings per share.
In other news, VP Heidi S. Margulis sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $231.96, for a total transaction of $347,940.00. Following the sale, the vice president now owns 8,150 shares of the company’s stock, valued at approximately $1,890,474. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Brian P. Leclaire sold 4,971 shares of the firm’s stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the sale, the senior vice president now directly owns 14,258 shares in the company, valued at approximately $3,421,920. The disclosure for this sale can be found here. 0.80% of the stock is owned by company insiders.
Large investors have recently modified their holdings of the company. Guardian Life Insurance Co. of America boosted its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after buying an additional 4 shares during the last quarter. Independent Portfolio Consultants Inc. boosted its stake in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares during the last quarter. Point72 Asia Hong Kong Ltd purchased a new stake in shares of Humana during the first quarter worth approximately $128,000. Westbourne Investment Advisors Inc. purchased a new stake in shares of Humana during the second quarter worth approximately $205,000. Finally, Hengehold Capital Management LLC purchased a new stake in shares of Humana during the second quarter worth approximately $209,000. 99.62% of the stock is currently owned by institutional investors and hedge funds.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.